文献速递临床试验与 GCP

专家与通科置入者在外周静脉导管置入中的比较:一项预试验随机对照试验

Expert versus generalist inserters for peripheral intravenous catheter insertion: a pilot randomised controlled trial.
PubMed 文献 · Trials · 2018-10-17

该单中心平行组预试验随机对照试验纳入138例内外科患者,比较血管通路专家与通科护士或医生置入外周静脉导管(PVC)的可行性。预设可行性标准均达到,通科组PVC失败率54%高于专家组的48%,两组均无PVC相关感染,专家组成员置入时间与满意度更优。

要点

  • 预设可行性标准均达到,支持开展多中心大样本随机对照试验。
  • 通科组PVC失败率54%(27/50)高于专家组48%(33/69),但置信区间跨1。
  • 专家组全部69例置入成功,通科组19例(28%)未置入PVC。

核心结论

  • 该预试验证实了开展大型多中心随机对照试验检验PVC置入模型的可行性和必要性。

研究设计与样本

  • 单中心、平行组预试验随机对照试验,在澳大利亚一家大型三级医院纳入138例内外科患者。
  • 比较血管通路专家与任何护理或医疗临床医生(通科模型)置入PVC。

主要发现

  • 通科组PVC失败27/50(54%),专家组33/69(48%),每1000 PVC日228对217,发生率比1.05(95%CI 0.61-1.80)。
  • 两组均无局部或PVC相关感染。
  • 专家组全部69例PVC置入成功;通科组19例(28%)患者未置入PVC。
  • 平均置入操作时间专家组2分钟,通科组11分钟。
  • 总体满意度(11分制,0=不满意,10=满意)专家组(n=43)中位数7,通科组(n=20)中位数4.5。

关键数值与推荐

  • 可行性标准:92%的筛查患者合格;2例患者拒绝参与;无失访或结局数据缺失。
  • 成本效果分析数据不足。

临床怎么用

  • 专家置入模型可能提高置入成功率和患者满意度并缩短操作时间,但需大型多中心随机对照试验验证。

局限性

  • 预试验样本量小,成本效果分析数据不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peripheral intravenous catheters (PVCs) are essential invasive devices, with 2 billion PVCs sold each year. The comparative efficacy of expert versus generalist inserter models for successful PVC insertion and subsequent reliable vascular access is unknown. METHODS: A single-centre, parallel-group, pilot randomised controlled trial (RCT) of 138 medical/surgical patients was conducted in a large tertiary hospital in Australia to compare PVC insertion by (1) a vascular access specialist (VAS) or (2) any nursing or medical clinician (generalist model). The primary outcome was the feasibility of a larger RCT as established by predetermined criteria (eligibility, recruitment, retention, protocol adherence). Secondary outcomes were PVC failure: phlebitis, infiltration/extravasation, occlusion, accidental removal or partial dislodgement, local infection or catheter-related bloodstream infection; dwell time; insertion success, insertion attempts; patient satisfaction; and procedural cost-effectiveness. RESULTS: Feasibility outcomes were achieved: 92% of screened patients were eligible; two patients refused participation; there was no attrition or missing outcome data. PVC failure was higher with generalists (27/50, 54%) than with VASs (33/69, 48%) (228 versus 217 per 1000 PVC days; incidence rate ratio 1.05, 95% confidence interval 0.61-1.80). There were no local or PVC-related infections in either group. All PVCs (n = 69) were successfully inserted in the VAS group. In the generalist group, 19 (28%) patients did not have a PVC inserted. There were inadequate data available for the cost-effectiveness analysis, but the mean insertion procedure time was 2 min in the VAS group and 11 min in the generalist group. Overall satisfaction with the PVC was measured on an 11-point scale (0 = not satisfied and 10 = satisfied) and was higher in the VAS group (n = 43; median = 7) compared to the generalist group (n = 20; median = 4.5). The multivariable model identified medical diagnosis and bed-bound status as being significantly associated with higher PVC failure, and securement with additional non-sterile tape was significantly associated with lower PVC failure. CONCLUSION: This pilot trial confirmed the feasibility and need for a large, multicentre RCT to test these PVC insertion models. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12616001675415 . Registered on 6 December 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Marsh N, Webster J, Larsen E, et al. Expert versus generalist inserters for peripheral intravenous catheter insertion: a pilot randomised controlled trial. Trials. 2018. PMID: 30333063. doi:10.1186/s13063-018-2946-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。